Spectra Industri (513687)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Reported ROE of 8.14% indicates positive return on equity, rare for such a microcap.
• Piotroski F-Score of 5/9 suggests some fundamental metrics are healthy despite operational stress.
• Price at ₹5.40 is about 45% above the 52-week low of ₹3.71, showing some recent buyer interest.
• Tiny market cap of ₹4 crore gives optionality if a niche auto-component revival occurs.

Concerns

• Latest quarter has ₹0 sales and ₹1 crore net loss, meaning no visible operating revenue.
• ROCE of -40.85% shows serious capital destruction in the business.
• Book value, debt/equity, and promoter holding are not available, so no margin of safety can be calculated.
• No dividend and P/E of 0.00 leave shareholders with no earnings or income support.

AI Analysis

At first glance, ₹5.40 and a ₹4 crore market cap makes Spectra Industri look like a classic penny stock. But I have learned that a low share price is not the same as cheap. This company had zero sales in the latest quarter and reported a net loss of ₹1 crore. A business that is not selling anything cannot be valued on earnings; the P/E of 0.00 tells me there are no earnings to put in the denominator. The ROCE of -40.85% is alarming: for every ₹100 deployed in this business, it is losing roughly ₹41. That is capital destruction. I notice a positive ROE of 8.14%, and a Piotroski F-Score of 5/9. But when operating capital is losing money at this rate, a positive ROE makes me question whether the profit comes from operations or from non-recurring items. Profit growth of 16.89% is also difficult to trust with a latest negative quarter. Growth off a losing or zero base is not the same as earnings power. Graham taught me to insist on a margin of safety. Here, I do not have book value, debt-to-equity ratio, or promoter holding. Without those, I cannot judge whether ₹4 crore is above or below the true asset value. There is no dividend, so I am not being paid to wait. The 52-week range of ₹3.71 to ₹6.47 shows the shares are not far from the top, so there is no obvious distress discount at the current price. This looks like a potential turnaround situation, but it is not yet investable. I need to see real sales, positive operating returns, and clear financial statements before applying value-investing discipline. Until then, this belongs in the too-hard pile.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer